Abstract Details

Title Saliva Soluble HLA Class II in MS: A Potential Marker of Response to Treatment with Interferon-Beta1a (Rebif)

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 141

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Alireza Minagar, MD	No disclosure on file
Irena Adamashvili, PhD	No disclosure on file
Roger E. Kelley, Jr., MD, FAAN (LSU Health Sciences Center)	Dr. Kelley has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����